Aflibercept

Aflibercept (INN, USAN) is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap. As the active ingredient of Zaltrap, the substance is called ziv-aflibercept in the US.

单词	Zaltrap
释义	Zaltrap 英语百科 Aflibercept Aflibercept (INN, USAN) is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap. As the active ingredient of Zaltrap, the substance is called ziv-aflibercept in the US.
随便看	hyperactivism hyperactivity Hyperactivity Disorder hyperactivity hyperkinesia Hyperactivity,Motor hyperactivity of cardiac fire hyperactivity of deficient fire hyperactivity of fire due to yin deficiency hyperactivity of hypopyrexia hyperactivity of ministerial fire hyperactivity of renal fire hyperactivity of yang due to yin deficiency Hyperactivity,Psychomotor hyperactivity syndrome hyperacuities hyperacuity Hyperacuses Hyperacusia Hyperacusias hyperacusic hyperacusis hyperacusis,hyperacousia,hyperacusia hyperacute Hyperacute graft rejection hyperacute injury phase